Investing Profile

Rajesh Chopra

InvestorVC
Venture Partner and Head of Oncology at ATP (Apple Tree Partners)
Photo of Rajesh Chopra, Venture Partner at ATP (Apple Tree Partners)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4900 CONNECTIONS
Hotmail Network
4900 CONNECTIONS
Hotmail Network
4900 CONNECTIONS
UCL Network
104 CONNECTIONS
UCL Network
104 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
CompanyStageDateRound SizeTotal Raised
Aethon Therapeutics
Series AJan 2023$30M
$30M
Co-investors: Paul Da Silva Jardine (ATP (Apple Tree Partners)), Seth L. Harrison (ATP (Apple Tree Partners))
Marengo Therapeutics
Series BNov 2021$80M
$80M
Co-investors: Joseph A. Yanchik III (ATP (Apple Tree Partners)), Andrew Bayliffe (ATP (Apple Tree Partners))
MRC Clinical Research Fellow UCLPresent
Director of Bone Marrow Transplantation GLASGOW ROYAL INFIRMARYPresent
Postdoctoral Research Fellow WEHI (Walter and Eliza Hall Institute of Medical Research)Present
Director of Haematological Oncology and Stem Cell Transplantation HotmailPresent
Group Leader HotmailPresent
Senior Lecturer The University of ManchesterPresent
Medical Science Director AstraZenecaPresent
Corporate Vice President of Translational Research CelgenePresent
Professor of Translational Cancer Discovery, Director of Cancer Research (UK) Cancer Therapy Unit HotmailPresent
Chief Scientific Officer Prologue MedicinesPresent
Venture Partner and Head of Oncology ATP (Apple Tree Partners)Present
UCL BSc; MBBS; FRCP, FRCPath, PhD Medicine , Cell and Molecular Biology
UCL BSc; MBBS; FRCP FRCPath, PhD, Medicine , Cell and Molecular Biology